🌎 Headlines and Analysts' Ratings for 12/31/2019

Ratings changes for Advanced Micro Devices, Tandem Diabetes Care, Wave Life Sciences, Sol Gel Technologies, Jaguar Health, NVIDIA, Sol Gel Technologies and more...Add MarketBeat to your address book or safe-sender list to make sure that your newsletter gets delivered to your inbox every time. Click here to learn how.	Unsubscribe.
Save $100.00 on Your Subscription to MarketBeat Daily Premium (Ends Tonight!!) Why Upgrade to MarketBeat Daily Premium? You'll receive actionable news, ratings, excerpts from research notes, earnings, dividends, insider trades, options activity and technical data for stocks you're interested in, a full 30 minutes before the NYSE opens. You'll get breaking news alerts via email or SMS when important news happens for stocks on your watchlist. You'll be able to follow an unlimited number of stocks on your watchlist and in our portfolio monitoring tool (My MarketBeat). You'll get additional ratings and price target changes which are not included in the free version of MarketBeat Daily. You'll receive our closing bell wrap-up that contains mid-day analyst ratings changes, earnings announcements and headlines. You'll get a summary of all of the key earnings announcements, dividend announcements and insider trades of the day. You'll have the option to receive your newsletter in an easy-to-scan table format and the ability to export each day's data to Microsoft Excel. Click Here to Subscribe to MarketBeat Daily Premium (Save $100.00!)
December 31st, 2019
Quick Links: My MarketBeat, Account Settings, Analyst Ratings, Company Profiles, Dividend Declarations, Earnings Announcements, Headlines & Insider Trades. Here are today's top stories and analysts' upgrades, downgrades and new coverage, brought to you by MarketBeat: Today's Top Stories Paul Meeks: Apple (AAPL) Could See a 40% Drop Could Rite Aid Be On The Verge of A Mammoth Short Squeeze? THIS Marijuana SuperGreenhouse Is About To Change the Weed Market (Ad) Nomura Gets Bullish On Goodyear Turnaround How to Hedge Your Portfolio for a Market Sell-Off 2019 Stock Market in Review The Risk Of A Market Correction In 2020 Hits New Highs Amazon Stock May Have an Achilles' Heel in One Key Indicator He's Picked a New Takeover Every 70 Days! (Ad) How major US stock indexes fared Tuesday Final goodbye: Recalling influential people who died in 2019 Sina, Tencent Music rise; McDermott, Core Laboratories fall Stocks close out best year since 2013; S&P 500 soars 28.9% Stocks close out their best year since 2013; S&P 500 index gains 28.9%, led by huge gains in technology companies 1 Stock for the Death of the iPhone (Ad) Slogging iPhone sales and slower consumer upgrades have caused investor confidence to plummet. And while Apple is pivoting for what Forbes has called the "iPhone Apocalypse," there's one company 350X smaller than Apple that is front and center to capitalize on a potential $7 trillion gold rush! Click here to get the full story Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. Analysts' Upgrades NIO (NYSE:NIO) was upgraded by analysts at Bank of America Corp from an "underperform" rating to a "neutral" rating. They now have a $3.80 price target on the stock, up previously from $2.10. 5.5% downside from the current price of $4.02. Read More. View today's most recent analysts' upgrades at MarketBeat.com Tap these 65 "Inbox Money" Secrets... (Ad) 65 "Mailbox Money" secrets ANYONE can collect! Everyone can use extra cash these days... And that's exactly why income expert - Neil George - is giving away his latest book... Titled Income For Life, this massive book profiles 65 unique streams of income, capable of generating an extra $237...$1,245...or even $10,312 each and every month. Click here to learn how to reserve claim your FREE copy today! Analysts' Downgrades Wave Life Sciences (NASDAQ:WVE) was downgraded by analysts at Leerink Swann from an "outperform" rating to a "market perform" rating. They now have a $10.00 price target on the stock, down previously from $33.00. 24.8% upside from the current price of $8.02. Read More. Wave Life Sciences (NASDAQ:WVE) was downgraded by analysts at Svb Leerink Llc from an "outperform" rating to a "market perform" rating. They now have a $10.00 price target on the stock, down previously from $33.00. 24.8% upside from the current price of $8.02. Read More. View today's most recent analysts' downgrades at MarketBeat.com $17M System Releases its Next Pick on this Free Broadcast (Ad) Roger's "Overnight Fortune" stock picks have been 8X more profitable than buy Amazon in 1997, turning a tiny $3k model portfolio into over $17M. And he's about to give you the ticker symbol of its next pick... Access the Broadcast Here Analysts' New Coverage BellRing Brands (NYSE:BRBR) is now covered by analysts at Consumer Edge. They set an "equal weight" rating and a $24.00 price target on the stock. 12.7% upside from the current price of $21.29. Read More. New Residential Investment (NYSE:NRZ) is now covered by analysts at Argus. They set a "buy" rating and a $18.00 price target on the stock. 11.7% upside from the current price of $16.11. Read More. View today's most recent analysts' new coverage at MarketBeat.com How in the *!@$ Did the CEO of a $3 Stock Do This?? (Ad) He made a $450 million deal with Nokia...a $395 million deal with Microsoft...an $828 million deal with Cisco...and a $29.26 BILLION deal with Apple. How did the CEO of a stock trading for just $3 do it? And just how high will the stock go as a result? The incredible story here. Analysts' Price Target Changes Advanced Micro Devices (NASDAQ:AMD) had its price target raised by analysts at Rosenblatt Securities from $52.00 to $65.00. They now have a "buy" rating on the stock. 41.7% upside from the current price of $45.86. Read More. Activision Blizzard (NASDAQ:ATVI) had its price target raised by analysts at Credit Suisse Group AG from $67.00 to $69.00. They now have an "outperform" rating on the stock. 16.1% upside from the current price of $59.42. Read More. BioXcel Therapeutics (NASDAQ:BTAI) had its price target raised by analysts at Canaccord Genuity from $24.00 to $27.00. They now have a "buy" rating on the stock. 84.8% upside from the current price of $14.61. Read More. Core Laboratories (NYSE:CLB) had its price target lowered by analysts at Cowen Inc from $42.00 to $39.00. They now have a "market perform" rating on the stock. 3.5% upside from the current price of $37.67. Read More. Core Laboratories (NYSE:CLB) had its price target lowered by analysts at JPMorgan Chase & Co. from $50.00 to $47.00. They now have a "neutral" rating on the stock. 24.8% upside from the current price of $37.67. Read More. Hain Celestial Group (NASDAQ:HAIN) had its price target raised by analysts at Jefferies Financial Group Inc from $25.00 to $30.00. They now have a "buy" rating on the stock. 15.6% upside from the current price of $25.96. Read More. Maxar Technologies (NYSE:MAXR) had its price target raised by analysts at National Bank Financial from $12.50 to $16.00. They now have a "sector perform" rating on the stock. 2.1% upside from the current price of $15.67. Read More. NVIDIA (NASDAQ:NVDA) had its price target raised by analysts at Benchmark Co. from $240.00 to $275.00. They now have a "buy" rating on the stock. 16.9% upside from the current price of $235.30. Read More. Sol Gel Technologies (NASDAQ:SLGL) had its price target raised by analysts at HC Wainwright from $23.00 to $26.00. They now have a "buy" rating on the stock. 51.6% upside from the current price of $17.15. Read More. Sol Gel Technologies (NASDAQ:SLGL) had its price target raised by analysts at JMP Securities from $20.00 to $33.00. They now have an "outperform" rating on the stock. 92.4% upside from the current price of $17.15. Read More. Sol Gel Technologies (NASDAQ:SLGL) had its price target raised by analysts at Jefferies Financial Group Inc from $14.00 to $24.00. They now have a "buy" rating on the stock. 39.9% upside from the current price of $17.15. Read More. Urovant Sciences (NASDAQ:UROV) had its price target raised by analysts at HC Wainwright from $28.00 to $33.00. They now have a "buy" rating on the stock. 112.8% upside from the current price of $15.51. Read More. Walmart (NYSE:WMT) had its price target raised by analysts at Morgan Stanley from $125.00 to $130.00. They now have an "overweight" rating on the stock. 9.4% upside from the current price of $118.84. Read More. View more analysts' coverage at MarketBeat.com U.K. Analysts' Ratings Barclays (LON:BARC) was given a new GBX 220 ($2.89) price target on by analysts at JPMorgan Chase & Co.. They now have a "buy" rating on the stock. Read More. Bango (LON:BGO) had its "corporate" rating reaffirmed by analysts at FinnCap. Read More. BT Group - CLASS A (LON:BT.A) was given a new GBX 155 ($2.04) price target on by analysts at Barclays PLC. They now have a "sell" rating on the stock. Read More. Diageo (LON:DGE) was given a new GBX 3,600 ($47.36) price target on by analysts at Jefferies Financial Group Inc. They now have a "buy" rating on the stock. Read More. Diageo (LON:DGE) was given a new GBX 3,570 ($46.96) price target on by analysts at Credit Suisse Group AG. They now have a "buy" rating on the stock. Read More. Eco Animal Health Group (LON:EAH) had its "buy" rating reaffirmed by analysts at Peel Hunt. Read More. London Stock Exchange Group (LON:LSE) was given a new GBX 7,700 ($101.29) price target on by analysts at UBS Group AG. They now have a "neutral" rating on the stock. Read More. National Grid (LON:NG) was given a new GBX 980 ($12.89) price target on by analysts at Deutsche Bank AG. They now have a "buy" rating on the stock. Read More. Reckitt Benckiser Group (LON:RB) was given a new GBX 6,300 ($82.87) price target on by analysts at Goldman Sachs Group Inc. They now have a "neutral" rating on the stock. Read More. Rio Tinto (LON:RIO) was given a new GBX 4,630 ($60.91) price target on by analysts at HSBC Holdings plc. They now have a "neutral" rating on the stock. Read More. View more analysts' coverage at MarketBeat.com Canadian Analysts' Ratings Goodfood Market (TSE:FOOD) had its "outperform" rating reaffirmed by analysts at National Bank Financial. They now have a C$4.25 price target on the stock. 35.8% upside from the current price of $3.13. Read More. View more analysts' coverage at MarketBeat.com More Calendars from MarketBeat: U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Corporate Buybacks, Cryptocurrencies, Cryptocurrency Offerings (ICOs), Dividend Declarations, Earnings Announcements, Earnings Conference Calls, Economic Reports, Gap Up/Down Stocks, Insider Trades, Initial Public Offerings (IPOs), Most Active Stocks, Percentage Gainers/Decliners, Sector Performance, Short Interest, Stock Splits, Unusual Options Volume & Unusual Trading Volume. Join Our Facebook Group: Click here to join MarketBeat's free stock discussion and trading idea group on Facebook. Upgrade Your Subscription: Upgrade to MarketBeat Daily Premium and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact us via email at contact@marketbeat.com or leave us a voice mail at (844) 978-6257. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2019 American Consumer News, LLC dba MarketBeat. 326 E 8th St #108, Sioux Falls, SD 57103. United States.